Following the press release of December 10th 2007, where Lavipharm announced the approval to market its fentanyl patch in Germany in anticipation that the launch would take place within the second half of 2008, on 25 September 2008, the Company announces that the product has just been launched, making Germany the second European market after Greece. The fentanyl patch, produced at Lavipharm’s manufacturing facilities in Peania, Attica, is sold in Germany by Mylan Dura, former Merck Dura GmbH, under the brand name Fentanyl Dura. National and pan European approvals in other markets are pending.

Read more: http://www.lavipharm.gr/english/contact/index.asp?section=news&art_id=380

Or return to the HBio news page